Unpredictable saccharin reinforcement enhances locomotor responding to amphetamine

Behavioural Brain Research

Volumn 226, Issue 1, 2012, Pages 340-344

  Singer, B F ^a   Scott Railton, J ^a   Vezina, P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Addiction; Locomotion; Self administration; Sensitization; Sucrose

Indexed keywords

AMPHETAMINE; SACCHARIN;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DOPAMINE RELEASE; FIXED RATIO; IMPULSIVENESS; LOCOMOTION; MATHEMATICAL PARAMETERS; NONHUMAN; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; SENSITIZATION; TRAINING; VARIABLE RATIO;

AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; MOTIVATION; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT SCHEDULE; REWARD; SACCHARIN; SELF ADMINISTRATION; SWEETENING AGENTS;

EID: 80054838051     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.09.003     Document Type: Article

References (61)

1. Vezina P. Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs. Neurosci Biobehav Rev 2004, 27:827-839.
2. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
3. Vezina P., Lorrain D.S., Arnold G.M., Austin J.D., Suto N. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci 2002, 22:4654-4662.
4. Vezina P., McGehee D.S., Green W.N. Exposure to nicotine and sensitization of nicotine-induced behaviors. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1625-1638.
5. Vanderschuren L.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl) 2000, 151:99-120.
6. Avena N.M., Hoebel B.G. A diet promoting sugar dependency causes behavioral cross-sensitization to a low dose of amphetamine. Neurosciences 2003, 122:17-20.
7. Avena N.M., Hoebel B.G. Amphetamine-sensitized rats show sugar-induced hyperactivity (cross-sensitization) and sugar hyperphagia. Pharmacol Biochem Behav 2003, 74:635-639.
8. Gosnell B.A. Sucrose intake enhances behavioral sensitization produced by cocaine. Brain Res 2005, 1031:194-201.
9. Baldo V., Cristofoletti M., Majori S., Cibin M., Peron C., Dal Zotto A., et al. Relationship between pathological gambling, alcoholism and drug addiction. Ann Ig 2006, 18:147-153.
10. Sellman J.D., Adamson S., Robertson P., Sullivan S., Coverdale J. Gambling in mild-moderate alcohol-dependent outpatients. Subst Use Misuse 2002, 37:199-213.
11. Steinberg M.A., Kosten T.A., Rounsaville B.J. Cocaine abuse and pathological gambling. Am J Addiction 1992, 1:121-132.
12. Hall G.W., Carriero N.J., Takushi R.Y., Montoya I.D., Preston K.L., Gorelick D.A. Pathological gambling among cocaine-dependent outpatients. Am J Psychiatry 2000, 157:1127-1133.
13. Zack M., Poulos C.X. Parallel roles for dopamine in pathological gambling and psychostimulant addiction. Curr Drug Abuse Rev 2009, 2:11-25.
14. Zack M., Poulos C.X. Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 2004, 29:195-207.
15. Berns G.S., McClure S.M., Pagnoni G., Montague P.R. Predictability modulates human brain response to reward. J Neurosci 2001, 21:2793-2798.
16. Breiter H.C., Aharon I., Kahneman D., Dale A., Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001, 30:619-639.
17. D'Ardenne K., McClure S.M., Nystrom L.E., Cohen J.D. BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 2008, 319:1264-1267.
18. Linnet J., Moller A., Peterson E., Gjedde A., Doudet D. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 2011, 106:383-390.
19. Elliott R., Newman J.L., Longe O.A., Deakin J.F. Differential response patterns in the striatum and orbitofrontal cortex to financial reward in humans: a parametric functional magnetic resonance imaging study. J Neurosci 2003, 23:303-307.
20. Galvan A., Hare T.A., Davidson M., Spicer J., Glover G., Casey B.J. The role of ventral frontostriatal circuitry in reward-based learning in humans. J Neurosci 2005, 25:8650-8656.
21. Volkow N.D., Wang G-, Fowler J.S., Logan J., Gatley S.J., Wong C., et al. Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D2 receptors. J Pharmacol Exp Ther 1999, 291:409-415.
22. Boileau I., Dagher A., Leyton M., Gunn R.N., Baker G.B., Diksic M., et al. Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry 2006, 63:1386-1395.
23. Perry J.L., Morgan A.D., Anker J.J., Dess N.K., Carroll M.E. Escalation of i.v. cocaine self-administration and reinstatement of cocaine-seeking behavior in rats bred for high and low saccharin intake. Psychopharmacology 2006, 186:235-245.
24. Avena N.M., Rada P., Hoebel B.G. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 2008, 32:20-39.
25. Stewart R.B., Russell R.N., Lumeng L., Li T.K., Murphy J.M. Consumption of sweet, salty, sour, and bitter solutions by selectively bred alcohol-preferring and alcohol-nonpreferring lines of rats. Alcohol Clin Exp Res 1994, 18:375-381.
26. Eiler W.J.A., Woods J.E., Masters J., McKay P.F., Hardy L., Goergen J.J., et al. Brain stimulation reward performance and sucrose maintained behaviors in alcohol-preferring and nonpreferring rats. Alcohol Clin Exp Res 2005, 29:571-583.
27. Doyon W.M., Ramachandra V., Samson H.H., Czachowski C.L., Gonzales R.A. Accumbal dopamine concentration during operant self-administration of a sucrose or a novel sucrose with ethanol solution. Alcohol 2004, 34:261-271.
28. Hajnal A., Smith G.P., Norgren R. Oral sucrose stimulation increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 2004, 286:R31-R37.
29. Hajnal A., Norgren R. Repeated access to sucrose augments dopamine turnover in the nucleus accumbens. Neuroreport 2002, 13:2213-2216.
30. Avena N.M., Rada P., Moise N., Hoebel B.G. Sucrose sham feeding on a binge schedule releases accumbens dopamine repeatedly and eliminates the acetylcholine satiety response. Neurosciences 2006, 139:813-820.
31. Bello N.T., Lucas L.R., Hajnal A. Repeated sucrose access influences dopamine D2 receptor density in the striatum. Neuroreport 2002, 13:1575-1578.
32. Spangler R., Wittkowski K.M., Goddard N.L., Avena N.M., Hoebel B.G., Leibowitz S.F. Opiate-like effects of sugar on gene expression in reward areas of the rat brain. Mol Brain Res 2004, 124:134-142.
33. Colantuoni C., Schwenker J., McCarthy J., Rada P., Ladenheim B., Cadet J-, et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 2001, 12:3549-3552.
34. Bello N.T., Sweigart K.L., Lakoski J.M., Norgren R., Hajnal A. Restricted feeding with scheduled sucrose access results in an upregulation of the rat dopamine transporter. Am J Physiol Regul Integr Comp Physiol 2003, 284:R1260-R1268.
35. Spangler R., Goddard N.L., Avena N.M., Hoebel B.G., Leibowitz S.F. Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. Mol Brain Res 2003, 111:74-83.
36. Unterwald E.M., Kreek M.J., Cuntapay M. The frequency of cocaine administration impacts cocaine-induced receptor alterations. Brain Res 2001, 900:103-109.
37. Shilling P.D., Kelsoe J.R., Segal D.S. Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci Lett 1997, 236:131-134.
38. Hietala J., West C., Syvalahti E., Nagren K., Lehikoinen P., Sonninen P., et al. Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 1994, 116:285-290.
39. Carelli R.M., Deadwyler S.A. A comparison of nucleus accumbens neuronal firing patterns during cocaine self-administration and water reinforcement in rats. J Neurosci 1994, 14:7736-7746.
40. Carelli R.M., Ijames S.G., Crumling A.J. Evidence that separate neural circuits the nucleus accumbens encode cocaine versus 'natural' (water and food) reward. J Neurosci 2000, 20:4255-4266.
41. Carelli R.M. Nucleus accumbens cell firing during goal-directed behaviors for cocaine vs 'natural' reinforcement. Physiol Behav 2002, 76:379-387.
42. Deadwyler S.A. Electrophysiological correlates of abused drugs: relation to natural rewards. Ann N Y Acad Sci 2010, 1187:140-147.
43. Lajtha A., Sershen H. Heterogeneity of reward mechanisms. Neurochem Res 2010, 35:851-867.
44. Fiorillo C.D., Tobler P.N., Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003, 299:1898-1902.
45. Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen T.J., Comings D.E. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 1995, 5:121-141.
46. Noble E.P. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. Eur J Psychiatry 2000, 15:79-89.
47. Zack M., Poulos C.X.A. D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacol 2007, 32:1678-1686.
48. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Gifford A., et al. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 1999, 156:1440-1443.
49. Volkow N.D., Wang G.J., Fowler J.S., Thanos P.P., Logan J., Gatley S.J., et al. Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study. Synapse 2002, 46:79-82.
50. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
51. Pehek E.A. Comparison of effects of haloperidol administration on amphetamine-stimulated dopamine release in the rat medial prefrontal cortex and dorsal striatum. J Pharmacol Exp Ther 1999, 289:14-23.
52. Dodd M.L., Klos K.J., Bower J.H., Geda Y.E., Josephs K.A., Ahlskog J.E. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005, 62:1377-1381.
53. Driver-Dunckley E., Samanta J., Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003, 61:422-423.
54. Grosset K.A., Macphee G., Pal G., Stewart D., Watt A., Davie J., et al. Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 2006, 21:2206-2208.
55. Molina J.A., Sainz-Artiga M.J., Fraile A., Jimenez-Jimenez F.J., Villanueva C., Orti-Pareja M., et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?. Mov Disord 2000, 15:869-872.
56. Dagher A., Robbins T.W. Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 2009, 61:502-510.
57. Johnson P.S., Madden G.J., Brewer A.T., Pinkston J.W., Fowler S.C. Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats. Psychopharmacology (Berl) 2011, 213:11-18.
58. Bordet R., Ridray S., Carboni S., Diaz J., Sokoloff P., Schwartz J.C. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Acad Sci USA 1997, 94:3363-3367.
59. Segal D.M., Moraes C.T., Mash D.C. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res 1997, 45:335-339.
60. Staley J.K., Mash D.C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996, 16:6100-6106.
61. Le Foll B., Goldberg S.R., Sokoloff P. The dopamine D3 receptor and drug dependence: effects on reward or beyond?. Neuropharmacology 2005, 49:525-541.